Autolus Therapeutics (AUTL) FCF Margin (2017 - 2025)
Historic FCF Margin for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 341.17%.
- Autolus Therapeutics' FCF Margin changed N/A to 341.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 557.85%, marking a year-over-year increase of 14778900.0%. This contributed to the annual value of 2256.38% for FY2024, which is 69646400.0% up from last year.
- Latest data reveals that Autolus Therapeutics reported FCF Margin of 341.17% as of Q3 2025.
- In the past 5 years, Autolus Therapeutics' FCF Margin registered a high of 13.09% during Q3 2021, and its lowest value of 169124.14% during Q4 2024.
- In the last 5 years, Autolus Therapeutics' FCF Margin had a median value of 1427.34% in 2022 and averaged 18432.33%.
- Examining YoY changes over the last 5 years, Autolus Therapeutics' FCF Margin showed a top increase of 170689900bps in 2023 and a maximum decrease of -83458800bps in 2023.
- Over the past 5 years, Autolus Therapeutics' FCF Margin (Quarter) stood at 13.09% in 2021, then tumbled by -3074bps to 415.39% in 2022, then crashed by -2372bps to 10267.49% in 2023, then crashed by -1547bps to 169124.14% in 2024, then skyrocketed by 100bps to 341.17% in 2025.
- Its FCF Margin was 341.17% in Q3 2025, compared to 382.63% in Q2 2025 and 933.07% in Q1 2025.